NASDAQ:ATRC
AtriCure, Inc.
AtriCure, Inc.'s revenue grew 14.9% in fiscal 2025 to $534.5M while operating margin rose to −1.8%. Free cash flow was $48.3M, 9.0% of revenue, and the diluted share count rose 1.7%.Summary generated from AtriCure, Inc.'s SEC filings. Latest annual report filed Feb 19, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$534.5M
Revenue growth+14.9%
Revenue, 5-yr CAGR+20.9%
Gross margin75.0%
Operating margin−1.8%
Net margin−2.1%
ROIC−1.9%
Return on equity−2.4%
Debt / equity0.13
Free cash flow$48.3M
FCF margin9.0%
Share count change+1.7%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 274 | 330 | 399 | 465 | 535 |
| Operating income | 55 | −43 | −27 | −40 | −9 |
| Net income | 50 | −46 | −30 | −45 | −11 |
| Free cash flow | −24 | −39 | −8 | 1 | 48 |
Recent filings
- 4Insider transaction report
Sep 24, 2026 - 4Insider transaction report
Sep 14, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Jul 27, 2026 - 8-KResults of operations and financial condition
Jul 23, 2026 - 8-KDirector or officer change
May 19, 2026 - 10-QQuarterly report for the period ended Mar 31, 2026
May 6, 2026 - 8-K/AAmended results of operations and financial condition
May 6, 2026 - 8-KResults of operations and financial condition
May 5, 2026